Your session is about to expire
← Back to Search
Behavioral Intervention
Virtual Reality for ADHD
Phase 2
Waitlist Available
Led By Joshua M Langberg, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants must be between the ages of 18 and 25
Be between 18 and 65 years old
Must not have
Participants not meeting criteria for ADHD or not in the specified age range
Participants with a history of seizures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured immediately after the 6th and 11th vr intervention sessions and in the post-intervention surveys (taking place over a total of 1-1.5 months)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a virtual reality program to help young adults with ADHD focus better while doing homework and studying. Participants will use a virtual reality headset and some will also receive feedback on their focus levels.
Who is the study for?
This trial is for young adults aged 18-25 with ADHD. Participants should be currently enrolled in an educational program and have regular homework or study tasks. They must not have any conditions that would interfere with VR headset use, such as severe motion sickness or epilepsy.
What is being tested?
The trial is testing a virtual reality program using the Meta Quest 3 VR Headset to improve focus during homework and studying for those with ADHD. It compares three groups: one using just the VR headset, another using the VR headset plus feedback on their focus levels, and a control group without these interventions.
What are the potential side effects?
Potential side effects may include discomfort from wearing the VR headset, eye strain, headaches, dizziness or nausea due to motion sickness associated with virtual reality environments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 25 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have ADHD and I am outside the specified age range.
Select...
I have a history of seizures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured immediately after the 6th and 11th vr intervention sessions and in the post-intervention surveys (taking place over a total of 1-1.5 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured immediately after the 6th and 11th vr intervention sessions and in the post-intervention surveys (taking place over a total of 1-1.5 months)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Concentration
Productivity Rate
System usability and satisfaction
Secondary study objectives
Effort
Motivation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Reality + FeedbackExperimental Treatment1 Intervention
Participants in this condition wear the virtual reality headset. They are emersed in a virtual world that looks like a cabin room with windows. They are sitting at a desk and can see their laptop screen as part of the virtual world. The program tracks their keyboard and mouse click data to assess how consistently they are working. A stoplight in the virtual environment is green when they are working consistently and turns red when the not.
Group II: Virtual RealityExperimental Treatment1 Intervention
Participants in this condition wear the virtual reality headset. They are emersed in a virtual world that looks like a cabin room with windows. They are sitting at a desk and can see their laptop screen as part of the virtual world.
Group III: VR PassthroughActive Control1 Intervention
Participants in this condition wear the same VR headset as participants in the in the other arms. However, they see directly through to their laptop and are not emersed in the virtual world.
Find a Location
Who is running the clinical trial?
Rutgers, The State University of New JerseyLead Sponsor
454 Previous Clinical Trials
69,832 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,933 Previous Clinical Trials
2,741,433 Total Patients Enrolled
96 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
21,125 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Louisiana State University Health Sciences Center in New OrleansOTHER
120 Previous Clinical Trials
42,699 Total Patients Enrolled
Joshua M Langberg, PhDPrincipal InvestigatorRutgers University
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
60 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)